Statins may cut delirium risk in ICU patients

Critically ill patients who continued their statin therapy while being treated in intensive care units were less likely to experience delirium than those who did not take statins, according to a study in the American Journal of Respiratory and Critical Care Medicine. Patients who were given statins the previous evening were more than twice as likely not to experience delirium. "These results suggest that in patients receiving statins prior to ICU admission, statin therapy should be continued to prevent delirium, albeit with appropriate safety monitoring," researchers said.

View Full Article in:

U.S. News & World Report · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC